CMCT
Creative Media & Community Trust Corporation
REIT - Office
Market Cap$6M
5Y Perf.-100.0%
Compare Stocks
5 / 10Try these comparisons:
Stock Comparison
CMCT vs CLPR vs ALEX vs NXRT vs GMRE
Revenue, margins, valuation, and 5-year total return — side by side.
CLPR
Clipper Realty Inc.
REIT - Residential
Market Cap$50M
5Y Perf.-57.7%
ALEX
Alexander & Baldwin, Inc.
REIT - Retail
Market Cap$1.52B
5Y Perf.+82.2%
NXRT
NexPoint Residential Trust, Inc.
REIT - Residential
Market Cap$756M
5Y Perf.-6.8%
GMRE
Global Medical REIT Inc.
REIT - Healthcare Facilities
Market Cap$94M
5Y Perf.-35.4%
CMCT vs CLPR vs ALEX vs NXRT vs GMRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CMCT | CLPR | ALEX | NXRT | GMRE |
|---|---|---|---|---|---|
| Industry | REIT - Office | REIT - Residential | REIT - Retail | REIT - Residential | REIT - Healthcare Facilities |
| Market Cap | $6M | $50M | $1.52B | $756M | $94M |
| Revenue (TTM) | $117M | $153M | $207M | $252M | $148M |
| Net Income (TTM) | $-39M | $-20M | $65M | $-32M | $2M |
| Gross Margin | -10.3% | 80.2% | 46.5% | 91.1% | 68.8% |
| Operating Margin | 7.1% | 2.7% | 41.8% | 11.5% | 24.9% |
| Forward P/E | — | — | 31.1x | — | 595.7x |
| Total Debt | $510M | $0.00 | $506M | $1.56B | $654M |
| Cash & Equiv. | $15M | $31M | $11M | $14M | $7M |
CMCT vs CLPR vs ALEX vs NXRT vs GMRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CMCT
CLPR
ALEX
NXRT
GMRE
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Creative Media & Co… (CMCT) | 100 | 0.0 | -100.0% |
| Clipper Realty Inc. (CLPR) | 100 | 42.3 | -57.7% |
| Alexander & Baldwin… (ALEX) | 100 | 182.2 | +82.2% |
| NexPoint Residentia… (NXRT) | 100 | 93.2 | -6.8% |
| Global Medical REIT… (GMRE) | 100 | 64.6 | -35.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMCT vs CLPR vs ALEX vs NXRT vs GMRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ALEX leads in 5 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Creative Media & Community Trust Corporation is the stronger pick specifically for dividend income and shareholder returns. CLPR also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
CMCT
Creative Media & Community Trust Corporation
The Real Estate Income Play
CMCT is the #2 pick in this set and the best alternative if dividends is your priority.
- 100.0% yield, vs NXRT's 7.1%
Best for: dividends
CLPR
Clipper Realty Inc.
The Real Estate Income Play
CLPR ranks third and is worth considering specifically for growth exposure.
- Rev growth 3.0%, EPS growth -88.0%, 3Y rev CAGR 5.7%
- 3.0% FFO/revenue growth vs ALEX's -12.7%
Best for: growth exposure
ALEX
Alexander & Baldwin, Inc.
The Real Estate Income Play
ALEX carries the broadest edge in this set and is the clearest fit for sleep-well-at-night and defensive.
- Lower volatility, beta 0.27, Low D/E 51.2%, current ratio 1.01x
- Beta 0.27, yield 4.3%, current ratio 1.01x
- Lower P/E (31.1x vs 595.7x)
- 31.3% margin vs CMCT's -33.4%
Best for: sleep-well-at-night and defensive
NXRT
NexPoint Residential Trust, Inc.
The REIT Holding
NXRT lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: real estate exposure
GMRE
Global Medical REIT Inc.
The Real Estate Income Play
GMRE is the clearest fit if your priority is income & stability and long-term compounding.
- Dividend streak 5 yrs, beta 0.48, yield 63.5%
- 308.1% 10Y total return vs ALEX's 75.5%
Best for: income & stability and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CLPR | 3.0% FFO/revenue growth vs ALEX's -12.7% |
| Value | ALEX | Lower P/E (31.1x vs 595.7x) |
| Quality / Margins | ALEX | 31.3% margin vs CMCT's -33.4% |
| Stability / Safety | ALEX | Beta 0.27 vs CMCT's 1.20, lower leverage |
| Dividends | CMCT | 100.0% yield, vs NXRT's 7.1% |
| Momentum (1Y) | ALEX | +24.9% vs CMCT's -99.0% |
| Efficiency (ROA) | ALEX | 3.9% ROA vs CMCT's -4.5%, ROIC 3.5% vs 0.8% |
CMCT vs CLPR vs ALEX vs NXRT vs GMRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
FY 2024
Segment breakdown not available.
Segment breakdown not available.
CMCT vs CLPR vs ALEX vs NXRT vs GMRE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLALEXLAGGINGGMRE
Who Leads Where
ALEX leads in 3 of 6 categories
CMCT leads 0 • CLPR leads 0 • NXRT leads 0 • GMRE leads 0 • 3 tied
Explore the data ↓GMREGlobal Medical REIT I…
0leads
NXRTNexPoint Residential …
0leads
CLPRClipper Realty Inc.
0leads
CMCTCreative Media & Comm…
0leads
ALEXAlexander & Baldwin, …
3leads
6 Total Categories
CATEGORYLEADERvs CMCTvs CLPRMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
Tied
—
Valuation MetricsMultiples, price ratios, and targets
Tied
—
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ALEX6/9
Total Returns1Y, 3Y, 5Y total returns with dividends
ALEX4/6
Risk & VolatilityBeta, volatility, and downside exposure
ALEX2/2
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
Evenly matched — ALEX and NXRT each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NXRT is the larger business by revenue, generating $252M annually — 2.2x CMCT's $117M. ALEX is the more profitable business, keeping 31.3% of every revenue dollar as net income compared to CMCT's -33.4%. On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CMCTCreative Media & … | CLPRClipper Realty In… | ALEXAlexander & Baldw… | NXRTNexPoint Resident… | GMREGlobal Medical RE… |
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $117M | $153M | $207M | $252M | $148M |
| EBITDAEarnings before interest/tax | $35M | $36M | $110M | $125M | $95M |
| Net IncomeAfter-tax profit | -$39M | -$20M | $65M | -$32M | $2M |
| Free Cash FlowCash after capex | -$15M | $7M | $27M | $79M | $19M |
| Gross MarginGross profit ÷ Revenue | -10.3% | +80.2% | +46.5% | +91.1% | +68.8% |
| Operating MarginEBIT ÷ Revenue | +7.1% | +2.7% | +41.8% | +11.5% | +24.9% |
| Net MarginNet income ÷ Revenue | -33.4% | -13.0% | +31.3% | -12.7% | +1.7% |
| FCF MarginFCF ÷ Revenue | -12.9% | +4.5% | +13.2% | +31.2% | +12.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.6% | -2.6% | -18.4% | +0.5% | +18.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +97.5% | -5.3% | -69.5% | 0.0% | -166.2% |
Evenly matched — ALEX and NXRT each lead in 2 of 6 comparable metrics.
Valuation Metrics
Evenly matched — CMCT and CLPR each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 23.4x trailing earnings, ALEX trades at a 80% valuation discount to GMRE's 115.3x P/E. On an enterprise value basis, CLPR's 0.6x EV/EBITDA is more attractive than ALEX's 23.3x.
| Metric | CMCTCreative Media & … | CLPRClipper Realty In… | ALEXAlexander & Baldw… | NXRTNexPoint Resident… | GMREGlobal Medical RE… |
|---|---|---|---|---|---|
| Market CapShares × price | $6M | $50M | $1.5B | $756M | $94M |
| Enterprise ValueMkt cap + debt − cash | $500M | $20M | $2.0B | $2.3B | $741M |
| Trailing P/EPrice ÷ TTM EPS | -0.10x | -6.64x | 23.42x | -23.65x | 115.29x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 31.10x | — | 595.67x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.37x | — | — |
| EV / EBITDAEnterprise value multiple | 14.15x | 0.55x | 23.32x | 18.60x | 8.35x |
| Price / SalesMarket cap ÷ Revenue | 0.05x | 0.33x | 7.34x | 3.01x | 0.68x |
| Price / BookPrice ÷ Book value/share | 0.02x | — | 1.54x | 2.52x | 0.17x |
| Price / FCFMarket cap ÷ FCF | — | 2.23x | 55.58x | 9.05x | — |
Evenly matched — CMCT and CLPR each lead in 2 of 6 comparable metrics.
Profitability & Efficiency
ALEX leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ALEX delivers a 6.4% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-13 for CMCT. ALEX carries lower financial leverage with a 0.51x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), ALEX scores 6/9 vs CMCT's 2/9, reflecting solid financial health.
| Metric | CMCTCreative Media & … | CLPRClipper Realty In… | ALEXAlexander & Baldw… | NXRTNexPoint Resident… | GMREGlobal Medical RE… |
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -13.4% | — | +6.4% | -10.1% | +0.5% |
| ROA (TTM)Return on assets | -4.5% | -1.6% | +3.9% | -1.7% | +0.2% |
| ROICReturn on invested capital | +0.8% | +0.6% | +3.5% | +1.1% | +2.0% |
| ROCEReturn on capital employed | +1.1% | +0.3% | +4.5% | +1.5% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 6 | 4 | 4 |
| Debt / EquityFinancial leverage | 1.91x | — | 0.51x | 5.18x | 1.18x |
| Net DebtTotal debt minus cash | $494M | -$31M | $495M | $1.5B | $647M |
| Cash & Equiv.Liquid assets | $15M | $31M | $11M | $14M | $7M |
| Total DebtShort + long-term debt | $510M | $0 | $506M | $1.6B | $654M |
| Interest CoverageEBIT ÷ Interest expense | 0.03x | — | 3.13x | 0.47x | 1.14x |
ALEX leads this category, winning 6 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
ALEX leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALEX five years ago would be worth $13,537 today (with dividends reinvested), compared to $402 for CMCT. Over the past 12 months, ALEX leads with a +24.9% total return vs CMCT's -99.0%. The 3-year compound annual growth rate (CAGR) favors ALEX at 8.3% vs CMCT's -65.5% — a key indicator of consistent wealth creation.
| Metric | CMCTCreative Media & … | CLPRClipper Realty In… | ALEXAlexander & Baldw… | NXRTNexPoint Resident… | GMREGlobal Medical RE… |
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -98.1% | -9.7% | +0.9% | +2.6% | +6.9% |
| 1-Year ReturnPast 12 months | -99.0% | -14.2% | +24.9% | -15.2% | +0.1% |
| 3-Year ReturnCumulative with dividends | -95.9% | -23.0% | +26.9% | -15.5% | +5.6% |
| 5-Year ReturnCumulative with dividends | -96.0% | -42.4% | +35.4% | -23.0% | -21.4% |
| 10-Year ReturnCumulative with dividends | -59.4% | -50.9% | +75.5% | +211.1% | +308.1% |
| CAGR (3Y)Annualised 3-year return | -65.5% | -8.3% | +8.3% | -5.5% | +1.8% |
ALEX leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
ALEX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ALEX is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than CMCT's 1.20 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALEX currently trades 99.1% from its 52-week high vs CMCT's 0.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CMCTCreative Media & … | CLPRClipper Realty In… | ALEXAlexander & Baldw… | NXRTNexPoint Resident… | GMREGlobal Medical RE… |
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.20x | 0.95x | 0.27x | 0.62x | 0.48x |
| 52-Week HighHighest price in past year | $1441.00 | $4.61 | $21.02 | $38.30 | $39.93 |
| 52-Week LowLowest price in past year | $3.60 | $2.83 | $15.07 | $23.79 | $29.05 |
| % of 52W HighCurrent price vs 52-week peak | +0.5% | +67.7% | +99.1% | +77.8% | +89.5% |
| RSI (14)Momentum oscillator 0–100 | 21.2 | 42.2 | 65.1 | 71.0 | 52.7 |
| Avg Volume (50D)Average daily shares traded | 3.9M | 70K | 1.6M | 216K | 130K |
ALEX leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Evenly matched — CMCT and NXRT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ALEX as "Buy", NXRT as "Hold", GMRE as "Buy". Consensus price targets imply 11.9% upside for GMRE (target: $40) vs -9.4% for NXRT (target: $27). For income investors, CMCT offers the higher dividend yield at 100.00% vs ALEX's 4.32%.
| Metric | CMCTCreative Media & … | CLPRClipper Realty In… | ALEXAlexander & Baldw… | NXRTNexPoint Resident… | GMREGlobal Medical RE… |
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $20.95 | $27.00 | $40.00 |
| # AnalystsCovering analysts | — | — | 8 | 10 | 22 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +13.9% | +4.3% | +7.1% | +63.5% |
| Dividend StreakConsecutive years of raises | 0 | 0 | 5 | 12 | 5 |
| Dividend / ShareAnnual DPS | $23.89 | $0.43 | $0.90 | $2.11 | $22.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.8% | 0.0% | +0.4% | +1.0% | 0.0% |
Evenly matched — CMCT and NXRT each lead in 1 of 2 comparable metrics.
Key Takeaway
ALEX leads in 3 of 6 categories — strongest in Profitability & Efficiency and Total Returns. 3 categories are tied.
Best OverallAlexander & Baldwin, Inc. (ALEX)Leads 3 of 6 categories
Loading custom metrics...
CMCT vs CLPR vs ALEX vs NXRT vs GMRE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CMCT or CLPR or ALEX or NXRT or GMRE a better buy right now?
For growth investors, Clipper Realty Inc.
(CLPR) is the stronger pick with 3. 0% revenue growth year-over-year, versus -12. 7% for Alexander & Baldwin, Inc. (ALEX). Alexander & Baldwin, Inc. (ALEX) offers the better valuation at 23. 4x trailing P/E (31. 1x forward), making it the more compelling value choice. Analysts rate Alexander & Baldwin, Inc. (ALEX) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CMCT or CLPR or ALEX or NXRT or GMRE?
On trailing P/E, Alexander & Baldwin, Inc.
(ALEX) is the cheapest at 23. 4x versus Global Medical REIT Inc. at 115. 3x. On forward P/E, Alexander & Baldwin, Inc. is actually cheaper at 31. 1x.
03Which is the better long-term investment — CMCT or CLPR or ALEX or NXRT or GMRE?
Over the past 5 years, Alexander & Baldwin, Inc.
(ALEX) delivered a total return of +35. 4%, compared to -96. 0% for Creative Media & Community Trust Corporation (CMCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus CMCT's -59. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CMCT or CLPR or ALEX or NXRT or GMRE?
By beta (market sensitivity over 5 years), Alexander & Baldwin, Inc.
(ALEX) is the lower-risk stock at 0. 27β versus Creative Media & Community Trust Corporation's 1. 20β — meaning CMCT is approximately 350% more volatile than ALEX relative to the S&P 500. On balance sheet safety, Alexander & Baldwin, Inc. (ALEX) carries a lower debt/equity ratio of 51% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CMCT or CLPR or ALEX or NXRT or GMRE?
By revenue growth (latest reported year), Clipper Realty Inc.
(CLPR) is pulling ahead at 3. 0% versus -12. 7% for Alexander & Baldwin, Inc. (ALEX). On earnings-per-share growth, the picture is similar: Creative Media & Community Trust Corporation grew EPS 98. 4% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Over a 3-year CAGR, GMRE leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CMCT or CLPR or ALEX or NXRT or GMRE?
Alexander & Baldwin, Inc.
(ALEX) is the more profitable company, earning 31. 3% net margin versus -33. 4% for Creative Media & Community Trust Corporation — meaning it keeps 31. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALEX leads at 32. 9% versus 2. 7% for CLPR. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CMCT or CLPR or ALEX or NXRT or GMRE more undervalued right now?
On forward earnings alone, Alexander & Baldwin, Inc.
(ALEX) trades at 31. 1x forward P/E versus 595. 7x for Global Medical REIT Inc. — 564. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 11. 9% to $40. 00.
08Which pays a better dividend — CMCT or CLPR or ALEX or NXRT or GMRE?
All stocks in this comparison pay dividends.
Creative Media & Community Trust Corporation (CMCT) offers the highest yield at 100. 0%, versus 4. 3% for Alexander & Baldwin, Inc. (ALEX).
09Is CMCT or CLPR or ALEX or NXRT or GMRE better for a retirement portfolio?
For long-horizon retirement investors, Alexander & Baldwin, Inc.
(ALEX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 27), 4. 3% yield). Both have compounded well over 10 years (ALEX: +75. 5%, CMCT: -59. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CMCT and CLPR and ALEX and NXRT and GMRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(CMCT: 3.6% · CLPR: -2.6%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.